CPHbiomedix ApS: Financial statements 2022
CVR: 43118676
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
CPHbiomedix ApS (CVR 43118676) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,341,829 and a net result of DKK 313,910. Equity in the 2022 report amounted to DKK 3,060,393. The solvency ratio was 92.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,341,829
- Profit/Loss
- DKK 313,910
- Equity
- DKK 3,060,393
- Total Assets
- DKK 3,304,571
- Employees
- 1
Official annual report
Keep an eye on CPHbiomedix ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of March 11, 2022, Claus Bo Vöge Christensen is registered as director of CPHbiomedix ApS.
CPHbiomedix ApS was founded on March 11, 2022.
About CPHbiomedix ApS
CPHbiomedix ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company has been dissolved on 9 November 2026. The company was registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 473,967 and a net result of DKK -21,956 compared with DKK 237,468 the year before. Equity in the 2025 report amounted to DKK 3,555,387.
